Rankings
▼
Calendar
PBYI (Puma Biotechnology, Inc.) Stock Financials & Earnings | Market Cap Arena
PBYI
Puma Biotechnology, Inc.
Mkt Cap
$311M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$228M
Net Income (TTM)
$31M
EPS (TTM)
$0.61
Free Cash Flow (TTM)
$48M
Gross Margin
74.5%
Op. Margin
16.3%
Net Margin
13.6%
FCF Margin
21.2%
P/S Ratio (TTM)
1.4x
P/E Ratio (TTM)
10.0x
YoY Rev Growth
-0.9%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$53M
$40M
$4M
Q2 23
$55M
$43M
$5M
Q3 23
$56M
$43M
$9M
Q4 23
$72M
$48M
$15M
Q1 24
$44M
$33M
-$2M
Q2 24
$47M
$36M
-$2M
Q3 24
$81M
$51M
$22M
Q4 24
$59M
$45M
$13M
Q1 25
$46M
$35M
$4M
Q2 25
$52M
$40M
$7M
Q3 25
$54M
$42M
$10M
Q4 25
$76M
$52M
$17M
marketcaparena.com
Revenue Breakdown
PBYI
Puma Biotechnology, Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1.3x
64.8x
Q2 23
1.4x
—
Q3 23
1.4x
83.8x
Q4 23
1.3x
14.4x
Q1 24
1.4x
20.3x
Q2 24
1.4x
35.7x
Q3 24
1.3x
13.4x
Q4 24
1.4x
10.3x
Q1 25
1.3x
8.2x
Q2 25
1.3x
6.4x
Q3 25
1.5x
8.4x
Q4 25
1.4x
10.0x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$3M
-$10M
Q2 23
$3M
$3M
Q3 23
$11M
$11M
Q4 23
$10M
$10M
Q1 24
$11M
$11M
Q2 24
$1M
$1M
Q3 24
$11M
$11M
Q4 24
$16M
$16M
Q1 25
$4M
$4M
Q2 25
$14M
$14M
Q3 25
$10M
$10M
Q4 25
$21M
$21M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$13M
Q2 23
$68K
Q3 23
$27K
Q4 23
$45K
Q1 24
$0
Q2 24
$20K
Q3 24
$20K
Q4 24
$16K
Q1 25
$61K
Q2 25
$20K
Q3 25
$26K
Q4 25
$142K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+15.4%
+4.1%
Q2 23
-8.3%
+4.7%
Q3 23
-1.7%
-13.1%
Q4 23
+9.9%
+3.1%
Q1 24
-17.1%
-4.8%
Q2 24
-13.7%
-0.8%
Q3 24
+43.5%
+23.0%
Q4 24
-18.2%
-20.3%
Q1 25
+5.1%
-8.8%
Q2 25
+11.4%
-7.0%
Q3 25
-32.4%
-23.2%
Q4 25
+27.8%
+27.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
5.4%
Q2 23
$2M
4.5%
Q3 23
$3M
4.5%
Q4 23
$2M
3.4%
Q1 24
$2M
5.4%
Q2 24
$2M
4.4%
Q3 24
$2M
2.6%
Q4 24
$2M
3.0%
Q1 25
$2M
4.4%
Q2 25
$2M
3.1%
Q3 25
$2M
3.1%
Q4 25
$6M
7.5%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$13M
$22M
—
—
Q2 23
$13M
$24M
—
—
Q3 23
$11M
$22M
—
—
Q4 23
$13M
$20M
$367K
—
Q1 24
$14M
$22M
$110K
—
Q2 24
$14M
$25M
—
—
Q3 24
$13M
$17M
—
—
Q4 24
$15M
$17M
—
—
Q1 25
$14M
$17M
—
—
Q2 25
$15M
$18M
—
—
Q3 25
$16M
—
—
$17M
Q4 25
$17M
—
—
$18M
marketcaparena.com
Revenue Segments
Product
Royalty
Quarter
Product
Royalty
Q1 23
$47M
$6M
Q2 23
$52M
$3M
Q3 23
$52M
$5M
Q4 23
$53M
$19M
Q1 24
$40M
$3M
Q2 24
$44M
$3M
Q3 24
$56M
$24M
Q1 25
$43M
$3M
Q2 25
$49M
$3M
Q3 25
$52M
$3M
Q4 25
$60M
$16M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$61M
$10M
$71M
Q2 23
$60M
$14M
$74M
Q3 23
$82M
$3M
$85M
Q4 23
$85M
$11M
$96M
Q1 24
$77M
$30M
$107M
Q2 24
$67M
$30M
$97M
Q3 24
$67M
$29M
$97M
Q4 24
$69M
$32M
$101M
Q1 25
$63M
$30M
$93M
Q2 25
$55M
$41M
$96M
Q3 25
$54M
$41M
$94M
Q4 25
$30M
$68M
$98M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
47M
+2.9%
Q2 23
47M
+0.1%
Q3 23
48M
+1.3%
Q4 23
48M
+0.5%
Q1 24
48M
+0.3%
Q2 24
48M
+0.2%
Q3 24
49M
+1.8%
Q4 24
49M
+0.5%
Q1 25
50M
+1.0%
Q2 25
50M
+0.5%
Q3 25
51M
+1.6%
Q4 25
52M
+1.2%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$0
120
FY 15
$0
156
FY 16
$0
160
FY 17
$87K
318
FY 18
$923K
272
FY 19
$1M
269
FY 20
$843K
267
FY 21
$1M
196
FY 22
$1M
192
FY 23
$1M
185
FY 24
$1M
172
FY 25
$7K
33K
marketcaparena.com